Growth Metrics

Innoviva (INVA) EBT Margin Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 441.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,297.00
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -492,898.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -492,898.00
Dec 31, 2025 -29,133.00
Sep 30, 2025 -2.19 Mn
Jun 30, 2025 -101,603.00
Mar 31, 2025 -366,150.00
Dec 31, 2024 -24,183.00
Sep 30, 2024 -11,822.00
Jun 30, 2024 -1.17 Mn
Mar 31, 2024 -747,052.00
Dec 31, 2023 -1.84 Mn
Sep 30, 2023 7,087.00
Jun 30, 2023 44,273.00
Mar 31, 2023 504,774.00
Dec 31, 2022 -107,517.00
Sep 30, 2022 2.19 Mn
Jun 30, 2022 100,030.00
Mar 31, 2022 353,002.00
Dec 31, 2021 -70,312.00
Sep 30, 2021 4,453.00
Jun 30, 2021 1.16 Mn
Mar 31, 2021 1.21 Mn
Dec 31, 2020 1.80 Mn
Sep 30, 2020 -1,303.00
Jun 30, 2020 8,826.00
Mar 31, 2020 7,911.00
Dec 31, 2019 3,555.00
Sep 30, 2019 4,265.00
Jun 30, 2019 4,847.00
Mar 31, 2019 6,946.00
Dec 31, 2018 7,276.00
Sep 30, 2018 11,513.00
Jun 30, 2018 15,769.00
Mar 31, 2018 21,259.00
Dec 31, 2017 26,236.00
Sep 30, 2017 222,701.00
Jun 30, 2017 218,909.00
Mar 31, 2017 211,610.00
Dec 31, 2016 66,074.00
Sep 30, 2016 232,304.00
Jun 30, 2016 15,622.00
Mar 31, 2016 273,693.00
Dec 31, 2015 -1,613.00
Sep 30, 2015 239,221.00
Jun 30, 2015 702,422.00
Mar 31, 2015 -22,193.00
Dec 31, 2014 47,141.00
Sep 30, 2014 -168,083.00
Jun 30, 2014 -173,573.00
Mar 31, 2014 -171,429.00